| Year |
Citation |
Score |
| 2021 |
Skovgard MS, Hocine HR, Saini JK, Moroz M, Bellis RY, Banerjee S, Morello A, Ponomarev V, Villena-Vargas J, Adusumilli PS. Imaging CAR T-cell kinetics in solid tumors: Translational implications. Molecular Therapy Oncolytics. 22: 355-367. PMID 34553024 DOI: 10.1016/j.omto.2021.06.006 |
0.428 |
|
| 2021 |
Moroz MA, Zurita J, Moroz A, Nikolov E, Likar Y, Dobrenkov K, Lee J, Shenker L, Blasberg R, Serganova I, Ponomarev V. Introducing a new reporter gene, membrane-anchored luciferase, for multiplex bioluminescence imaging. Molecular Therapy Oncolytics. 21: 15-22. PMID 33851009 DOI: 10.1016/j.omto.2021.03.004 |
0.516 |
|
| 2021 |
Volpe A, Pillarsetty NVK, Lewis JS, Ponomarev V. Applications of nuclear-based imaging in gene and cell therapy: probe considerations. Molecular Therapy Oncolytics. 20: 447-458. PMID 33718593 DOI: 10.1016/j.omto.2021.01.017 |
0.317 |
|
| 2020 |
Harmsen S, Medine EI, Moroz M, Nurili F, Lobo J, Dong Y, Turkekul M, Pillarsetty NVK, Ting R, Ponomarev V, Akin O, Aras O. A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking. Biomaterials. 269: 120630. PMID 33395580 DOI: 10.1016/j.biomaterials.2020.120630 |
0.369 |
|
| 2020 |
Volpe A, Nagle VL, Lewis JS, Ponomarev V. Predicting CAR-T cell immunotherapy success through immunoPET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33328345 DOI: 10.1158/1078-0432.CCR-20-4297 |
0.383 |
|
| 2020 |
Mane MM, Cohen IJ, Ackerstaff E, Shalaby K, Ijoma JN, Ko M, Maeda M, Albeg AS, Vemuri K, Satagopan J, Moroz A, Zurita J, Shenker L, Shindo M, Nickles T, ... ... Ponomarev V, et al. Lactate Dehydrogenase A Depletion Alters MyC-CaP Tumor Metabolism, Microenvironment, and CAR T Cell Therapy. Molecular Therapy Oncolytics. 18: 382-395. PMID 32913888 DOI: 10.1016/J.Omto.2020.07.006 |
0.434 |
|
| 2020 |
Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. PMID 32555459 DOI: 10.1038/S41586-020-2403-9 |
0.411 |
|
| 2019 |
Wang L, Cheung NV, Hoseini SS, Xu H, Ponomarev V. Silencing Fc domains in T Cell-Engaging Bispecific Antibodies Improves T-Cell Trafficking and Antitumor Potency. Cancer Immunology Research. PMID 31615814 DOI: 10.1158/2326-6066.Cir-19-0121 |
0.473 |
|
| 2019 |
Krebs S, Ponomarev V, Slovin S, Schöder H. Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 60: 879-881. PMID 31053682 DOI: 10.2967/Jnumed.119.227561 |
0.397 |
|
| 2019 |
Mane MM, Shalaby K, Cohen I, Albeg A, Ijoma J, Ko M, Maeda M, Vemuri K, Satagopan J, Moroz A, Zurita J, Shenker L, Ackerstaff E, Shindo M, Moroz E, ... ... Ponomarev V, et al. Abstract A089: The effect of lactate dehydrogenase-A (LDH-A) knockdown and human prostate-specific membrane antigen (hPSMA) directed CAR T-cell treatment on hPSMA(+) Myc-CaP tumors Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A089 |
0.492 |
|
| 2018 |
Krebs S, Ahad A, Carter L, Eyquem J, Brand C, Bell M, Ponomarev V, Reiner T, Meares CF, Gottschalk S, Sadelain M, Larson SM, Weber WA. Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903928 DOI: 10.2967/Jnumed.118.208041 |
0.491 |
|
| 2018 |
Lee JT, Moroz MA, Ponomarev V. Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes. Methods in Molecular Biology (Clifton, N.J.). 1790: 165-180. PMID 29858791 DOI: 10.1007/978-1-4939-7860-1_13 |
0.638 |
|
| 2018 |
Moroz MA, Zanzonico P, Lee JT, Ponomarev V. Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes. Methods in Molecular Biology (Clifton, N.J.). 1790: 153-163. PMID 29858790 DOI: 10.1007/978-1-4939-7860-1_12 |
0.618 |
|
| 2018 |
Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL, Cunanan KM, Gönen M, Ponomarev V, Zeglis BM, Souweidane MM, et al. PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29572254 DOI: 10.2967/Jnumed.117.205054 |
0.386 |
|
| 2018 |
Zysk A, DeNichilo MO, Zinonos I, Hay S, Liapis V, Ponomarev V, Zannettino AC, Evdokiou A, Panagopoulos V. Zoledronate Enhances the Cytotoxicity of Gamma Delta T Cell Immunotherapy in an Orthotopic Mouse Model of Osteolytic Osteosarcoma Journal of Cancer Science & Therapy. 10. DOI: 10.4172/1948-5956.1000554 |
0.41 |
|
| 2017 |
Kaittanis C, Andreou C, Hieronymus H, Mao N, Foss CA, Eiber M, Weirich G, Panchal P, Gopalan A, Zurita J, Achilefu S, Chiosis G, Ponomarev V, Schwaiger M, Carver BS, et al. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. The Journal of Experimental Medicine. PMID 29141866 DOI: 10.1084/Jem.20171052 |
0.335 |
|
| 2017 |
Liapis V, Zysk A, DeNichilo M, Zinonos I, Hay S, Panagopoulos V, Shoubridge A, Difelice C, Ponomarev V, Ingman W, Atkins GJ, Findlay DM, Zannettino ACW, Evdokiou A. Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. Cancer Medicine. 6: 2164-2176. PMID 28799237 DOI: 10.1002/Cam4.1115 |
0.412 |
|
| 2017 |
Serganova I, Moroz E, Cohen I, Moroz M, Mane M, Zurita J, Shenker L, Ponomarev V, Blasberg R. Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade. Molecular Therapy Oncolytics. 4: 41-54. PMID 28345023 DOI: 10.1016/J.Omto.2016.11.005 |
0.48 |
|
| 2017 |
Ponomarev V. Advancing Immune and Cell-Based Therapies Through Imaging. Molecular Imaging and Biology. 19: 379-384. PMID 28271366 DOI: 10.1007/S11307-017-1069-7 |
0.37 |
|
| 2017 |
Panagopoulos V, Leach DA, Zinonos I, Ponomarev V, Licari G, Liapis V, Ingman WV, Anderson P, DeNichilo MO, Evdokiou A. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. International Journal of Oncology. PMID 28260049 DOI: 10.3892/Ijo.2017.3883 |
0.336 |
|
| 2017 |
Zysk A, DeNichilo MO, Panagopoulos V, Zinonos I, Liapis V, Hay S, Ingman W, Ponomarev V, Atkins G, Findlay D, Zannettino A, Evdokiou A. Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters. 386: 141-150. PMID 27865798 DOI: 10.1016/J.Canlet.2016.11.013 |
0.403 |
|
| 2016 |
Lee JT, Zhang H, Moroz MA, Likar Y, Shenker L, Sumzin N, Lobo J, Zurita J, Collins J, van Dam RM, Ponomarev V. Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27393689 DOI: 10.1007/S11307-016-0981-6 |
0.545 |
|
| 2016 |
Liapis V, Zinonos I, Labrinidis A, Hay S, Ponomarev V, Panagopoulos V, Zysk A, DeNichilo M, Ingman W, Atkins GJ, Findlay DM, Zannettino AC, Evdokiou A. Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. Cancer Medicine. PMID 26749324 DOI: 10.1002/Cam4.599 |
0.409 |
|
| 2015 |
Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, et al. Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. PMID 26389576 DOI: 10.1038/Nbt.3349 |
0.45 |
|
| 2015 |
Moroz MA, Zhang H, Lee J, Moroz E, Zurita J, Shenker L, Serganova I, Blasberg R, Ponomarev V. Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1055-60. PMID 26025962 DOI: 10.2967/Jnumed.115.159855 |
0.609 |
|
| 2015 |
Liapis V, Labrinidis A, Zinonos I, Hay S, Ponomarev V, Panagopoulos V, DeNichilo M, Ingman W, Atkins GJ, Findlay DM, Zannettino AC, Evdokiou A. Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters. 357: 160-9. PMID 25444931 DOI: 10.1016/J.Canlet.2014.11.020 |
0.381 |
|
| 2014 |
Zinonos I, Luo KW, Labrinidis A, Liapis V, Hay S, Panagopoulos V, Denichilo M, Ko CH, Yue GG, Lau CB, Ingman W, Ponomarev V, Atkins GJ, Findlay DM, Zannettino AC, et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology. 45: 532-40. PMID 24865346 DOI: 10.3892/Ijo.2014.2468 |
0.345 |
|
| 2014 |
Moroz E, Moroz M, Serganova I, Zurita J, Lee J, Shah N, Ponomarev V, Blasberg R. Abstract 1120: Bioenergetics of T cells in the context of adoptive immunotherapy Cancer Research. 74: 1120-1120. DOI: 10.1158/1538-7445.Am2014-1120 |
0.566 |
|
| 2013 |
Ghosh A, Dogan Y, Moroz M, Holland AM, Yim NL, Rao UK, Young LF, Tannenbaum D, Masih D, Velardi E, Tsai JJ, Jenq RR, Penack O, Hanash AM, Smith OM, ... ... Ponomarev V, et al. Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity. The Journal of Clinical Investigation. 123: 2654-62. PMID 23676461 DOI: 10.1172/Jci66301 |
0.437 |
|
| 2012 |
O'Connor AE, Mc Gee MM, Likar Y, Ponomarev V, Callanan JJ, O'shea DF, Byrne AT, Gallagher WM. Mechanism of cell death mediated by a BF2-chelated tetraaryl-azadipyrromethene photodynamic therapeutic: dissection of the apoptotic pathway in vitro and in vivo. International Journal of Cancer. Journal International Du Cancer. 130: 705-15. PMID 21413012 DOI: 10.1002/Ijc.26073 |
0.399 |
|
| 2011 |
Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Findlay DM, Zannettino ACW, Evdokiou A. Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo Journal of Bone and Mineral Research. 26: 630-643. PMID 20818644 DOI: 10.1002/Jbmr.244 |
0.364 |
|
| 2010 |
Likar Y, Zurita J, Dobrenkov K, Shenker L, Cai S, Neschadim A, Medin JA, Sadelain M, Hricak H, Ponomarev V. A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1395-403. PMID 20810757 DOI: 10.2967/Jnumed.109.074344 |
0.376 |
|
| 2010 |
Das S, Ladell DS, Podgrabinska S, Ponomarev V, Nagi C, Fallon JT, Skobe M. Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Research. 70: 1814-24. PMID 20179201 DOI: 10.1158/0008-5472.Can-09-3675 |
0.309 |
|
| 2010 |
Klose AD, Beattie BJ, Dehghani H, Vider L, Le C, Ponomarev V, Blasberg R. In vivo bioluminescence tomography with a blocking-off finite-difference SP3 method and MRI/CT coregistration. Medical Physics. 37: 329-38. PMID 20175496 DOI: 10.1118/1.3273034 |
0.357 |
|
| 2009 |
Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Zannettino ACW, Findlay DM, Evdokiou A. Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer Molecular Cancer Therapeutics. 8: 2969-2980. PMID 19808976 DOI: 10.1158/1535-7163.Mct-09-0745 |
0.394 |
|
| 2009 |
Ponomarev V. Nuclear imaging of cancer cell therapies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1013-6. PMID 19525449 DOI: 10.2967/Jnumed.109.064055 |
0.45 |
|
| 2009 |
Labrinidis A, Hay S, Liapis V, Ponomarev V, Findlay DM, Evdokiou A. Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model Clinical Cancer Research. 15: 3451-3461. PMID 19401351 DOI: 10.1158/1078-0432.Ccr-08-1616 |
0.37 |
|
| 2009 |
Labrinidis A, Diamond P, Martin S, Hay S, Liapis V, Zinonos I, Sims NA, Atkins GJ, Vincent C, Ponomarev V, Findlay DM, Zannettino AC, Evdokiou A. Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1998-2009. PMID 19276263 DOI: 10.1158/1078-0432.Ccr-08-2444 |
0.373 |
|
| 2009 |
Likar Y, Dobrenkov K, Olszewska M, Shenker L, Cai S, Hricak H, Ponomarev V. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1273-82. PMID 19259663 DOI: 10.1007/S00259-009-1089-X |
0.364 |
|
| 2008 |
Xing L, Deng X, Kotedia K, Ackerstaff E, Ponomarev V, Clifton Ling C, Koutcher JA, Li GC. Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein. Acta Oncologica (Stockholm, Sweden). 47: 1211-20. PMID 18661431 DOI: 10.1080/02841860802256475 |
0.378 |
|
| 2008 |
Dobrenkov K, Olszewska M, Likar Y, Shenker L, Gunset G, Cai S, Pillarsetty N, Hricak H, Sadelain M, Ponomarev V. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1162-70. PMID 18552144 DOI: 10.2967/Jnumed.107.047324 |
0.527 |
|
| 2008 |
Ponomarev V. Imaging regulation of endogenous gene expression using spliceosome-mediated trans-splicing. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1035-7. PMID 18552134 DOI: 10.2967/Jnumed.107.049270 |
0.357 |
|
| 2008 |
Gade TP, Koutcher JA, Spees WM, Beattie BJ, Ponomarev V, Doubrovin M, Buchanan IM, Beresten T, Zakian KL, Le HC, Tong WP, Mayer-Kuckuk P, Blasberg RG, Gelovani JG. Imaging transgene activity in vivo. Cancer Research. 68: 2878-84. PMID 18413756 DOI: 10.1158/0008-5472.Can-07-6028 |
0.381 |
|
| 2008 |
Likar Y, Dobrenkov K, Olszewska M, Vider E, Shenker L, Cai S, Pillarsetty N, Hricak H, Ponomarev V. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 713-20. PMID 18413388 DOI: 10.2967/Jnumed.107.046425 |
0.368 |
|
| 2008 |
Henke E, Perk J, Vider J, de Candia P, Chin Y, Solit DB, Ponomarev V, Cartegni L, Manova K, Rosen N, Benezra R. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nature Biotechnology. 26: 91-100. PMID 18176556 DOI: 10.1038/Nbt1366 |
0.392 |
|
| 2007 |
Stephan MT, Ponomarev V, Brentjens RJ, Chang AH, Dobrenkov KV, Heller G, Sadelain M. T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nature Medicine. 13: 1440-9. PMID 18026115 DOI: 10.1038/Nm1676 |
0.459 |
|
| 2007 |
Brader P, Riedl CC, Woo Y, Ponomarev V, Zanzonico P, Wen B, Cai S, Hricak H, Fong Y, Blasberg R, Serganova I. Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Molecular Cancer Therapeutics. 6: 2900-8. PMID 17989317 DOI: 10.1158/1535-7163.Mct-07-0432 |
0.425 |
|
| 2007 |
Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nuclear Medicine and Biology. 34: 791-807. PMID 17921031 DOI: 10.1016/J.Nucmedbio.2007.05.009 |
0.441 |
|
| 2007 |
Bradbury MS, Panagiotakos G, Chan BK, Tomishima M, Zanzonico P, Vider J, Ponomarev V, Studer L, Tabar V. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. Journal of Neurochemistry. 102: 2029-39. PMID 17555555 DOI: 10.1111/J.1471-4159.2007.04681.X |
0.378 |
|
| 2007 |
Ponomarev V, Doubrovin M, Shavrin A, Serganova I, Beresten T, Ageyeva L, Cai C, Balatoni J, Alauddin M, Gelovani J. A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 819-26. PMID 17468435 DOI: 10.2967/Jnumed.106.036962 |
0.386 |
|
| 2006 |
Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 107: 3295-302. PMID 16380446 DOI: 10.1182/Blood-2005-07-2730 |
0.352 |
|
| 2006 |
Dobrenkov K, Dabrowska M, Shenker L, Vider E, Gunset G, Sadelain M, Ponomarev V. 763. Multimodality Imaging of Genetically Modified Lymphocytes In Vivo Molecular Therapy. 13: S295. DOI: 10.1016/J.Ymthe.2006.08.848 |
0.5 |
|
| 2005 |
Wu KD, Cho YS, Katz J, Ponomarev V, Chen-Kiang S, Danishefsky SJ, Moore MA. Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 10640-5. PMID 16030145 DOI: 10.1073/Pnas.0504512102 |
0.417 |
|
| 2005 |
Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. The Journal of Clinical Investigation. 115: 44-55. PMID 15630443 DOI: 10.1172/Jci22320 |
0.392 |
|
| 2005 |
Ertem SA, Wu K, Ponomarev V, Chin AC, Moore MA. The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models. Blood. 106: 3477-3477. DOI: 10.1182/Blood.V106.11.3477.3477 |
0.383 |
|
| 2004 |
Doubrovin M, Serganova I, Mayer-Kuckuk P, Ponomarev V, Blasberg RG. Multimodality in vivo molecular-genetic imaging. Bioconjugate Chemistry. 15: 1376-88. PMID 15546205 DOI: 10.1021/Bc0498572 |
0.379 |
|
| 2004 |
Doubrovin M, Ponomarev V, Blasberg RG. PET-based reporter gene imaging. Assessment of endogenous molecular-genetic events. Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society. 23: 38-50. PMID 15508384 DOI: 10.1109/Memb.2004.1337948 |
0.447 |
|
| 2004 |
Serganova I, Doubrovin M, Vider J, Ponomarev V, Soghomonyan S, Beresten T, Ageyeva L, Serganov A, Cai S, Balatoni J, Blasberg R, Gelovani J. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Research. 64: 6101-8. PMID 15342393 DOI: 10.1158/0008-5472.Can-04-0842 |
0.395 |
|
| 2004 |
Gade TP, Spees WM, Le HC, Zakian KL, Ponomarev V, Doubrovin M, Gelovani JG, Koutcher JA. In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method. Magnetic Resonance in Medicine. 52: 169-73. PMID 15236381 DOI: 10.1002/Mrm.20131 |
0.38 |
|
| 2004 |
Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, Ivanova A, Ageyeva L, Tourkova V, Balatoni J, Bornmann W, Blasberg R, Gelovani Tjuvajev J. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. European Journal of Nuclear Medicine and Molecular Imaging. 31: 740-51. PMID 15014901 DOI: 10.1007/S00259-003-1441-5 |
0.421 |
|
| 2004 |
Tourkova V, Dabrovska M, Doubrovin M, Serganova I, Vider J, Beresten T, Cai S, Finn R, Tjuvajev JG, Ponomarev V. 983. Human Derived Dual Reporter/Suicide Gene System for Simultaneous Pet Imaging of Independent Molecular-Biological Processes In Vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.921 |
0.394 |
|
| 2004 |
Tourkova V, Doubrovin M, Dabrowska M, Vider J, Cai S, Finn R, Tjuvajev JG, Ponomarev V. 258. Multi-Modality Non-Invasive Imaging of NK-92 Cells Trafficking and Tumor Targeting in Mice Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.199 |
0.431 |
|
| 2004 |
Doubrovin M, Mayer-Kuckuk P, Budak-Alpdogan T, Bidaut L, Cai S, Ponomarev V, Blasberg R, van den Brink M, Bertino J, Benarjee D, Gelovani J. 3-dimensional multi-modality non-invasive imaging of the bone marrow engraftment model Biology of Blood and Marrow Transplantation. 10: 82. DOI: 10.1016/J.Bbmt.2003.12.148 |
0.314 |
|
| 2003 |
Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, Beresten T, Ageyeva L, Sadelain M, Koutcher J, Blasberg RG, Gelovani Tjuvajev JG. Development of a new reporter gene system-dsRed/Xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier Molecular Imaging. 2: 93-112. PMID 12964307 DOI: 10.1162/153535003322331984 |
0.404 |
|
| 2003 |
Ponomarev V, Doubrovin M, Serganova I, Beresten T, Vider J, Shavrin A, Ageyeva L, Balatoni J, Blasberg R, Tjuvajev JG. Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. Neoplasia (New York, N.Y.). 5: 245-54. PMID 12869307 DOI: 10.1016/S1476-5586(03)80056-8 |
0.362 |
|
| 2003 |
Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes Nature Biotechnology. 21: 405-413. PMID 12652311 DOI: 10.1038/Nbt805 |
0.511 |
|
| 2002 |
Hackman T, Doubrovin M, Balatoni J, Beresten T, Ponomarev V, Beattie B, Finn R, Bornmann W, Blasberg R, Tjuvajev JG. Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Molecular Imaging. 1: 36-42. PMID 12920859 DOI: 10.1162/153535002753395699 |
0.361 |
|
| 2001 |
Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W, Finn R, Akhurst T, Larson S, Blasberg R, Sadelain M, Tjuvajev JG. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo Neoplasia. 3: 480-488. PMID 11774030 DOI: 10.1038/Sj.Neo.7900204 |
0.513 |
|
| 2001 |
Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, Humm J, Larson S, Sadelain M, Blasberg R, Tjuvajev JG. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo Proceedings of the National Academy of Sciences of the United States of America. 98: 9300-9305. PMID 11481488 DOI: 10.1073/Pnas.161091198 |
0.38 |
|
| Show low-probability matches. |